3 February 2021
Budget Impact Analysis I: A 6-Step Approach
LEVEL - Intermediate
TRACK - Economic Evaluation
LENGTH: 4 Hour | 1 Day Short Course
February 3, 2021 | 4 Hours plus 30 minute break:
08:00-12:30 Eastern Standard Time (EST)
13:00-17:30 Greenwich Mean Time (GMT)
14:00-18:30 Central European Time (CET)
Basic Schedule:
Class Time: 2 hours
Break: 30 minutes
Class Time: 2 hours
Click for time zone conversion
DESCRIPTION
This course will describe the methods used to estimate the budget impact of a new health care technology, and will present six basic steps for estimating budget impact: (1) estimating the target population; (2) selecting a time horizon; (3) identifying current and projected treatment mix; (4) estimating current and future drug costs; (5) estimating change in disease-related costs; and (6) estimating and presenting changes in annual budget impact and health outcomes. Both static and dynamic methods for estimating the budget and health impact of adding a new drug to a health plan formulary will be presented. These six steps will be illustrated using actual budget impact models. This course is designed for those with some experience with pharmacoeconomic analysis.
FACULTY MEMBERS
Stephanie R. Earnshaw, PhD, MS
Senior Vice President, Health Economics
RTI Health Solutions, Research Triangle Park, NC, USA
C. Daniel Mullins, PhD
Professor & Chair
University of Maryland, School of Pharmacy
Baltimore, MD, USA
Thor-Henrik Brodtkorb, PhD
Senior Director, Health Economics, RTI Solutions
Ljungskile, Sweden